CT Anatomy and Pathology of the Urinary System, Adrenal Glands and Prostate.
Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20...
Transcript of Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20...
![Page 1: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/1.jpg)
Prostate Cancer Grading
From Gleason to a Contemporary Patient
Centric Grading SystemJonathan I. Epstein
![Page 2: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/2.jpg)
Original Gleason System
• First reported in 1967 - 270 men
• Modified 1974 – 1032 men
• Modified 1977 – 2911 men
![Page 3: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/3.jpg)
Breakdown of Gleason Patterns2,911 cases (percentages added up to approximately 150% since 50% of the tumors showed at least two different patterns).
• Pattern 1 - 3.5% Pattern 2 - 24.4%• Pattern 3 - 87.7% Pattern 4 - 12.1%• Pattern 5 - 22.6%.
![Page 4: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/4.jpg)
Historical Prevalence of Gleason Score 2-4
• In the 1990s, 22% of prostate needle biopsies had as the highest grade a Gleason score of 2-4.
![Page 5: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/5.jpg)
Gleason Score 2-4 on Needle Should Not Be MadeEditorial AJSP (Epstein), 2000
• 1) Poor reproducibility among experts for lower grade tumors.
• 2) Correlation with the prostatectomy score for Gleason 2-4 tumors is poor and up to 50% of the corresponding prostatectomies may have extraprostatic extension.
• 3) Gleason 2-4 may misguide clinicians and patients into believing that there is an indolent tumor.
![Page 6: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/6.jpg)
Low Grade Prostate Cancer Does Exist
• Transition zone
• Small foci
• Seen on TURP – often indicates “insignificant” cancer
• Rarely sampled on needle biopsy – not indicate “indolent” tumor
![Page 7: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/7.jpg)
![Page 8: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/8.jpg)
![Page 9: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/9.jpg)
The 2005 International Society of Urological Pathology (ISUP) Consensus
Conference on Gleason Grading of Prostatic Carcinoma
The American Journal of Surgical Pathology: Volume 29. September 2005 pp 1228-1242
Epstein, Jonathan I ; Allsbrook, William C Jr; Amin, Mahul B; Egevad, Lars L and the ISUP Grading Committee
![Page 10: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/10.jpg)
WHY THE NEED FOR A CONSENSUS ON GLEASON GRADING?
![Page 11: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/11.jpg)
Gleason’s Era
• More advanced clinical disease• Fewer RPs which were not processed in entirety
– Grading of multiple nodules– Tertiary patterns
• Needle biopsy only a few thick cores– Grading thin needle cores– Grading multiple cores from different sites
• Lesions diagnosed differently with more modern tests• New entities
![Page 12: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/12.jpg)
![Page 13: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/13.jpg)
![Page 14: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/14.jpg)
Gleason Pattern 3
• Individual discrete glands with well-formed lumina
![Page 15: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/15.jpg)
![Page 16: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/16.jpg)
![Page 17: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/17.jpg)
![Page 18: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/18.jpg)
![Page 19: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/19.jpg)
![Page 20: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/20.jpg)
![Page 21: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/21.jpg)
![Page 22: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/22.jpg)
![Page 23: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/23.jpg)
Level 1 ? Pattern 4
![Page 24: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/24.jpg)
Level 2 – Glands Open Up Pattern 3
![Page 25: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/25.jpg)
Gleason Pattern 3
• Small well-circumscribed cribriform glands with uniform round evenly distributed lumina
![Page 26: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/26.jpg)
![Page 27: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/27.jpg)
American Journal of Surgical Pathology - 2008
Subsequent multiple articles showing cribriform prostatecancer associated with an adverse prognosis
![Page 28: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/28.jpg)
Consensus Conference on Grading of Prostatic Carcinoma
ChicagoNovember, 2014
![Page 29: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/29.jpg)
All Cribriform Cancer Glands are Graded as Gleason Pattern 4
![Page 30: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/30.jpg)
![Page 31: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/31.jpg)
Gleason Pattern 4
• Poorly-formed glands
![Page 32: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/32.jpg)
![Page 33: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/33.jpg)
![Page 34: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/34.jpg)
![Page 35: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/35.jpg)
![Page 36: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/36.jpg)
Gleason Pattern 4
• Fused glands
![Page 37: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/37.jpg)
![Page 38: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/38.jpg)
![Page 39: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/39.jpg)
Gleason Pattern 4
• Cribriform glands
![Page 40: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/40.jpg)
![Page 41: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/41.jpg)
![Page 42: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/42.jpg)
![Page 43: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/43.jpg)
![Page 44: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/44.jpg)
Gleason Pattern 4
• Glomeruloid glands
![Page 45: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/45.jpg)
![Page 46: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/46.jpg)
![Page 47: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/47.jpg)
![Page 48: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/48.jpg)
Gleason Pattern 5
• No gland formation or glands with necrosis
![Page 49: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/49.jpg)
![Page 50: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/50.jpg)
![Page 51: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/51.jpg)
![Page 52: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/52.jpg)
![Page 53: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/53.jpg)
![Page 54: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/54.jpg)
![Page 55: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/55.jpg)
![Page 56: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/56.jpg)
![Page 57: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/57.jpg)
![Page 58: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/58.jpg)
CONTEMPORARYPROSTATE CANCER GRADING IMAGES
Grading diagram that uses photomicrographs instead of line drawings to show the various patterns within each grade.
Sent to Pathologistsin >40 Countries
![Page 59: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/59.jpg)
VARIANTS of ADENOCARCINOMA
![Page 60: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/60.jpg)
Grading Variants of Prostate Adenocarcinoma
Same rule as grading usual prostate adenocarcinoma based on underlying grade pattern, except small cell carcinoma.
• Individual well-formed glands – pattern 3• Cribriform – pattern 4• Individual cells or necrosis – pattern 5
![Page 61: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/61.jpg)
Foamy Gland Cancer
Pseudohyperplastic Cancer
Colloid Carcinoma
Signet Ring Cell-Like Adenocarcioma
![Page 62: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/62.jpg)
Ductal Adenocarcinoma
• Cribriform/papillary ductal adenocarcinomas should be graded as Gleason score 4+4=8
• PIN-Like ductal adenocarcinoma graded 3+3=6.
• Duct adenocarcinoma with necrosis grades as Gleason pattern 5.
![Page 63: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/63.jpg)
Small Cell Carcinoma
Small cell carcinoma of the prostate has unique histological, immunohistochemical, and clinical features, which differ from those associated with Gleason pattern 5 prostatic acinar carcinoma, such that small cell carcinoma should not be assigned a Gleason grade.
![Page 64: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/64.jpg)
Post-Treatment Cancer – HT or RT
If histologically, ordinary prostate cancer is seen, which resembles non-treated cancer – “Cancer without significant treatment affect” and Gleason grade.
Histologically cancer is seen, yet shows treatment effect – “Cancer with significant treatment affect” and do not Gleason grade.
![Page 65: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/65.jpg)
Post Cryo or HIFU
• Following cryotherapy or HIFU, benign prostate tissue and prostate cancer undergoes infarction.
• Successful therapy eventually shows scarring, hemosiderin deposition, and maybe necrotic tumor.
• If non-necrotic tumor is seen, looks like non-treated cancer and can be graded and indicates viable active tumor that needs further treatment.
![Page 66: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/66.jpg)
Intraductal Carcinoma
• Do not grade intraductal carcinoma (IDC)
• Only do IHC if the overall highest grade per part in the case would change depending on whether IDC or infiltrating high grade carcinoma
![Page 67: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/67.jpg)
The International Society of Urological Pathology (ISUP) Consensus Conference
on Grading of Prostatic Carcinoma
ChicagoNovember, 2014
![Page 68: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/68.jpg)
67 Pathology Experts in Prostate Cancer from 21 Countries
20 Urology, Oncology, and Radiation Oncology Experts
![Page 69: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/69.jpg)
Reporting Rules for Gleason Grading
![Page 70: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/70.jpg)
Tertiary PatternsNo longer Used for Two Patterns
With Very Minor Component of Higher Grade
• 4+4=8 with minor pattern 5 behaves like 4+5=9 so now just called 4+5=9.
• 3+3=6 with minor pattern 4 is now called 3+4=7 with recording the percent pattern 4 ranging from 1%-approaching 50%.
• Optional how to record percent pattern 4 (per part or per case)
![Page 71: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/71.jpg)
Rationale for Reporting Percent Pattern 4
![Page 72: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/72.jpg)
IMPROVED PATIENT CARE
The major advantage for patient care to record the percent pattern 4 on needle for Gleason 3+4=7 is for active surveillance (AS). For the appropriate patient, Gleason 3+3=6 is accepted for men to undergo AS. However, there may be some men, depending on age, co-morbidity, extent of cancer, MRI findings, patient desire, etc, that could be a candidate for AS with 3+4=7 if the pattern 4 is limited. Currently, this information is not apparent in pathology reports.
![Page 73: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/73.jpg)
The amount of pattern 4 may not only be used for active surveillance but could be used for radiation therapy as well. Currently, there is different radiation therapy for 3+4 vs 4+3. In a case with borderline 3+4 vs 4+3, one pathologist could call it 3+4 and the other 4+3. Depending on whether 3+4 or 4+3 the percent pattern 4 could range from <5% to 90% and would not be evident in a report. By reporting the case as 3+4=7 (approaching 50% pattern 4) or 4+3=7 (60% pattern 4) the borderline nature of the case would be evident and clinicians could use other factors (PSA, number of cores positive, imaging, etc.) for therapy.
![Page 74: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/74.jpg)
PRACTICALITY
When a pathologist grades a specimen as 3+4 or 4+3, (s)he already has to decide what part of the tumor is pattern 4 or 3 such that to give a percent should not be that much extra effort.
“Interobserver reproducibility of reporting percent GG4/5 on prostate biopsies is at least as good as that of reporting Gleason score.” (J Urol 2004; 171:664-7)
Interobserver reproducibility of percent Gleason Pattern 4 on prostate biopsies is about 80%. (ASJP 2016; 40: 1686-1692).
![Page 75: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/75.jpg)
BORDERLINE 3+3 vs 3+4
Having to record less than 5 percent pattern 4 in a borderline case between 3+3 and 3+4 should prompt the pathologist to verify that the pattern 4 is definitive.
![Page 76: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/76.jpg)
Personal Preferences in My Practice• I do not record percent pattern 4 in small foci of
3+4=7 or 4+3=7.
• I record: <5%, 10%, 20%, 30%, 40%, approaching 50%, 60%, 70%, 80%, 90%
• I do not record percent pattern 4 if any other core has Gleason score 9 or 10.
• If borderline between lower and higher grade cancer, I assign the lower grade and look at levels.
![Page 77: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/77.jpg)
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
Eur Urol2016
Sauter et al.
![Page 78: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/78.jpg)
Tertiary PatternsThree Patterns With Very Minor Component of Higher Grade
• On RP if pattern 5 is <5% and 3rd most common pattern then report 3+4=7 with tertiary pattern 5. If >5% then is the secondary pattern (ie. 3+5=8).
• On needle bx. if pattern 5 is 3rd most common pattern, regardless of percentage, then include in score (ie. 3+5=8) (most common + highest grade).
• Only use “tertiary” for 3+4=7 with <5% (tertiary) pattern 5 or 4+3=7 with <5% (tertiary) pattern 5 on RP
![Page 79: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/79.jpg)
Minor Pattern of Lower Grade
• On RP or needle do not mention if the lower grade component is <5%.
• Core or RP nodule with 98% pattern 4 and 2% pattern 3 is graded as 4+4=8.
![Page 80: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/80.jpg)
NEEDLE BIOPSY WITH DIFFERENT CORES SHOWING DIFFERENT GRADES
One should assign individual Gleason scores to separate cores as long as the cores were submitted in separate containers or the cores were in the same container yet specified by the urologist as to their location (ie. by different color inks).
Assigning a global (composite) score is optional.
![Page 81: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/81.jpg)
Reporting of Gleason Grade in RPs
• Each major tumor focus should be graded separately. For example: 2 tumor nodules – One left PZ 4+4=8 with larger right PZ 3+3=6. Give two scores and not call 3+4=7.
• Typically only the largest tumor foci are graded. Not necessary to report small multifocal lower grade cancer.
• Exception when there is a smaller tumor focus of higher grade, report this Gleason score.
![Page 82: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/82.jpg)
Impetus for a New Prostate Cancer Grading System
![Page 83: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/83.jpg)
Movement to Rename Gleason Score 6 as not Cancer
![Page 84: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/84.jpg)
The Word “Cancer” Drives Overtreatment
• Fear of death from cancer likely plays some role, and removing the label “cancer” could reduce unnecessary treatment of low grade disease.
• Proposed name: IDLE (indolent lesion of epithelial origin) (Esserman, Lancet Oncol et al., 2013)
![Page 85: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/85.jpg)
Precedent in Other Organs
• Soft tissue: Well-differentiated liposarcoma in extremities renamed: Atypical lipomatous tumor (ALT)
• Bladder: Subset of low grade Papillary urothelial carcinoma renamed: Papillary urothelial neoplasm of low malignant potential (PUNLMP)
• Thyroid: Encapsulated follicular variant papillary thyroid carcinoma renamed: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
![Page 86: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/86.jpg)
Urol Clinics of N Am 2014; 41:339-46
![Page 87: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/87.jpg)
Arguments in Favor of Retention of Gleason Score 6 Cancer
• Morphological
• Molecular
• 20% undersampling of higher grade cancer with Gleason 6 on biopsy
• Patients will be lost to follow-up if called IDLE tumor
![Page 88: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/88.jpg)
Gleason Score 6 Prostatic Adenocarcinoma Should Still be Called
“Cancer”
• Rather there is a need to change what patients think when they hear they have Gleason score 6 cancer.
• Urologists need to reassure and educate patients.
• Modify how we report prostate cancer grade to more accurately reflect their behavior.
![Page 89: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/89.jpg)
Problems with Gleason System: Scale
• 6 is the lowest grade reported although the scale goes from 2-10
• Patients are told they have a Gleason score of 6 out of 10 and logically but incorrectly think that they have a tumor in the middle of the grade spectrum, contributing to the fear of cancer
![Page 90: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/90.jpg)
Qualitative Study About Grading• 7 focus groups with n=37 prostate cancer patients in two
clinical settings from 2015-2016
• Majority of patients (84%) agreed that it would be clearer ifgrades were reported on a scale of 1-5 instead of 6-10
• 88% would prefer to hear they have “Group 1” rather than“Gleason 6”
• 80% would feel more comfortable choosing active surveillance with “Group 1” versus “Gleason 6”
Loeb et al. (Unpublished data)
![Page 91: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/91.jpg)
Problems with Gleason System Grouping
• Gleason 7 is not homogeneous: 4+3=7 has a much worse prognosis than 3+4=7
• Gleason 8-10 is often considered as one group - high grade disease
![Page 92: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/92.jpg)
Problems with Gleason System:Inconsistent & Inaccurate Grouping
Various combinations have been used in the literature including some of the highest impact studies:
Prostate Cancer Outcomes Study (NEJM): 2-4; 5-7; 8-10Scandinavian Prostate Cancer Group Study (NEJM): 2-6, 7; 8-10Prostate Cancer Intervention vs. Observation (NEJM): 2-6; 7-10Prostate Cancer Prevention Trial (NEJM): 2-6; 7-10
![Page 93: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/93.jpg)
D’Amico Risk Classification Stratification
• Low Risk: T1C/T2a & PSA<10 & Gleason <6
• Intermed. Risk: T2b or PSA 10-20 or Gleason 7
• High Risk: T2c or PSA>20 or Gleason 8-10
![Page 94: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/94.jpg)
Problems with Gleason Grading Too Many Grades with Similar Prognoses• 1+1; 1+2; 1+3; 1+4; 1+5; 2+1; 2+2; 2+3; 2+4; 2+5;
3+1; 3+2; 3+3; 3+4; 3+5; 4+1; 4+2; 4+3; 4+4; 4+5; 5+1; 5+2; 5+3; 5+4; 5+5
• 25 potential grades!
• What are the least number of grades with a similar prognosis?
![Page 95: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/95.jpg)
BJU International 2013; 111:753-60
![Page 96: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/96.jpg)
New 5 Grade System
• Grade Group 1 (<6) Only individual discrete well-formed glands
• Grade Group 2 (3+4)Predominantly well-formed glands with a lesser component of poorly- formed/fused/cribriform glands
• Grade Group 3 (4+3)Predominantly poorly formed/fused/cribriform glands with a lesser component of well-formed glands
![Page 97: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/97.jpg)
• Grade Group 4 (4+4/3+5/5+3)Only poorly-formed/fused/cribriform glands orPredominantly mix of well-formed and lack of glands
• Grade Group 5 (4+5/5+4/5+5) Lack gland formation (or with necrosis) with or w/o poorly formed/fused/cribriform glands
![Page 98: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/98.jpg)
2014 - RP Data From 5 Institutions
• Since 2005 – Modified Gleason grades
• University of Pittsburgh – J. Nelson, A. Parwani• MSKCC – V. Reuter, S. Fine, A. Vickers, J. Eastham,
D. Sjoberg• CCF – C. Magi-Galluzzi, E. Klein, J. Ciezki, C. Reddy • Karolinska – L. Egevad, P. Wiklund, T. Nyberg• Johns Hopkins – J. Epstein, M. Han
![Page 99: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/99.jpg)
RP GradeMeta-Analysis
Hosp | Freq.------------+------------------Pittsburgh | 2,102 Karolinska | 3,763 Hopkins | 6,137 Memorial | 6,673 CCF | 2,170 ------------+-------------------
Total | 20,845
![Page 100: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/100.jpg)
GrGp 1
GrGp 2
GrGp 3
GrGp 4
GrGp 5
![Page 101: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/101.jpg)
RP Grade5 Year Biochemical Risk Free SurvivalGrade Gleason BRFS 95% Confidence
Intervals
1 3+3=6 96% 94%-95%2 3+4=7 88% 87%-89%3 4+3=7 63% 61%-65%4 4+4=8 48% 44%-52%5 9-10 26% 23%-30%
![Page 102: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/102.jpg)
Biopsy GradeMeta-Analysis
Hosp | Freq.------------+------------------Pittsburgh | 2,102 Hopkins | 6,137 Memorial | 5,791 CCF | 2,146 ------------+-------------------
Total | 16,176
![Page 103: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/103.jpg)
GrGp 1
GrGp 2
GrGp 3
GrGp 4
GrGp 5
![Page 104: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/104.jpg)
Radiation Therapy
CCF 2495 (45%)MSKCC 3006 (55%)
Brachy 3361 (61%)EBRT 2140 (39%)
Peri-RT 1845 (34%)HT
![Page 105: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/105.jpg)
GrGp1
GrGp 2GrGp3GrGp4
GrGp5
![Page 106: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/106.jpg)
VALIDATION OF A CONTEMPORARY PROSTATE CANCER GRADING SYSTEM WITH LONG TERM OUTCOME
B J CancerBerney D., et al.
2016
![Page 107: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/107.jpg)
Multiple Additional Studies Validating New Grading System
Correlating with BCR, distant metastases, mortality following RTand radical prostatectomy
![Page 108: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/108.jpg)
More Accurately Reflects Biology of Disease than Current System
Grade Group 1 (as opposed to 6/10): Excellent prognosis – no metastases. Avoids issues of GS<6
Grade Group 2 (as opposed to 7/10): Very good prognosis – rare metastases
Grade Group 3 (4+3 and 3+4 both = GS7 – D’Amico): Greater distinction from Grade Group 2
![Page 109: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/109.jpg)
More Accurately Reflects Biology of Disease than Current System
Grade Group 4 (as opposed to combined 8-10): Better prognosis than 9-10.
Grade Group 5: No need to distinguish 9 vs 10.
![Page 110: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/110.jpg)
The new grading system was recently accepted
2016 World Health Organization (WHO) Pathology & Genetics:
Tumours of the Urinary System and Male Genital System
College of American Pathologists (CAP)
AJCC Cancer Staging Manual –TNM Systen (8th Edition)
![Page 111: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/111.jpg)
Starting in January 2018, it will be mandatory for pathology laboratories accredited by CAP to use the new grading system in parallel to the Gleason grading system and to report percent pattern 4 for Gleason score 3+4=7 on needle biopsy.
Needle Biopsy: Adenocarcinoma of the prostate Gleasonscore 3+4=7 (Grade Group 2) with 20% pattern 4 involving 80% of 1 core.
Optional: Percent pattern 4 for 4+3=7 on needle biopsy
![Page 112: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/112.jpg)
• Mandatory to report Grade Groups and tertiary pattern 5 on RP
• Radical Prostatectomy: Adenocarcinoma of the prostate Gleason score 3+4=7 (Grade Group 2) with tertiary (<5%) pattern 5.
• Optional to report percent pattern 4 for Gleason 7 on RP
![Page 113: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/113.jpg)
![Page 114: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/114.jpg)
Controversy Gleason Score 3+5 & 5+3
• Conflicting studies on whether 3+5=8 & 5+3=8 should be in Grade Group 4 (along with Gleason score 4+4=8) or Grade Group 5 (along with Gleason Score 9-10)
• Needle Bx: Separate cores with 3+3=6 and 5+5=10. If average could be 3+5=8 or 5+3=8. If highest grade core would be 5+5=10.
• RP: Separate nodules with 3+3=6 and 5+5=10. If average or not process to determine if separate, then could be 3+5=8 or 5+3=8. If highest grade nodule would be 5+5=10.
![Page 115: Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason](https://reader034.fdocuments.in/reader034/viewer/2022043021/5f3d553d0a756c72c933a1d7/html5/thumbnails/115.jpg)
How Common is 5+3=8?
• Our prior multi-institutional study of over 20,000 men using highest grade core or highest grade nodule
• Only 4/20,824 (0.02%) radical prostatectomies and 6/16,172 (0.04%) needle biopsies were Gleason score 5+3=8